Immix Biopharma Stock Performance

Immix Biopharma Relative Risk vs. Return Landscape

If you would invest  404.00  in Immix Biopharma on November 16, 2025 and sell it today you would earn a total of  329.00  from holding Immix Biopharma or generate 81.44% return on investment over 90 days. Immix Biopharma is currently generating 1.141% in daily expected returns and assumes 5.7785% risk (volatility on return distribution) over the 90 days horizon. In different words, 51% of stocks are less volatile than Immix, and 77% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Immix Biopharma is expected to generate 7.5 times more return on investment than the market. However, the company is 7.5 times more volatile than its market benchmark. It trades about 0.2 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

Immix Biopharma Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 1.31 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Immix Biopharma will likely underperform. Moreover Immix Biopharma has an alpha of 1.3371, implying that it can generate a 1.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Immix Biopharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immix Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 1.89 7.67 13.45 Details

Intrinsic Valuation Low Real High 3.05 8.83 14.61 Details

1 Analysts Consensus Low Target High 10.07 11.07 12.28 Details

Earnings Estimates (0) Low Projected EPS High -0.14 -0.14 -0.14 Details

Immix Biopharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Immix Biopharma is not an exception. The market had few large corrections towards the Immix Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Immix Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Immix Biopharma within the framework of very fundamental risk indicators.

Immix Biopharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immix Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immix Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Immix Biopharma Price Density Drivers

Immix Biopharma Fundamentals Growth

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.